Hepatocyte nuclear factor 4
| Identifiers | |
| Symbol | HNF4A |
| Alt. Symbols | TCF14, MODY, MODY1 |
| Entrez | 3172 |
| HUGO | 5024 |
| OMIM | 600281 |
| PDB | 1M7W |
| RefSeq | NM_001030004 |
| UniProt | P41235 |
| Other data | |
| Locus | Chr. 20 q12-20q13.1 |
| Identifiers | |
| Symbol | HNF4G |
| Entrez | 3174 |
| HUGO | 5026 |
| OMIM | 605966 |
| PDB | 1LV2 |
| RefSeq | NM_004133 |
| UniProt | Q14541 |
| Other data | |
| Locus | Chr. 8 q21-q22 |
HNF4 (Hepatocyte Nuclear Factor 4) is a nuclear receptor protein mostly expressed in the liver, gut, kidney, and pancreatic beta cells that is critical for liver development. In humans, there are two isoforms of NHF4, alpha and gamma encoded by two separate gene HNF4A and HNF4G respectively.[1]
Ligands
HNF4 was originally classified as an orphan receptor. However HNF4 was found later to be constitutively active by virtue of being continuously bound to a variety of fatty acids.[2][3] The ligand binding domain of HNF4, as with other nuclear receptors, adopts a canonical alpha helical sandwich fold[4][5] and interacts with co-activator proteins.[6]
Pathology
Mutations in the HNF4-α gene have been linked to maturity onset diabetes of the young (MODY).[7]
See also
References
- ↑ Chartier FL, Bossu JP, Laudet V, Fruchart JC, Laine B (1994). "Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver". Gene 147 (2): 269-72. doi:10.1016/0378-1119(94)90079-5. PMID 7926813.
- ↑ Sladek F (2002). "Desperately seeking...something". Mol Cell 10 (2): 219-21. doi:10.1016/S1097-2765(02)00605-6. PMID 12191466.
- ↑ Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O (2005). "Fatty acid regulation of hepatic gene transcription". J Nutr 135 (11): 2503-6. PMID 16251601.
- ↑ Wisely GB, Miller AB, Davis RG, Thornquest AD Jr, Johnson R, Spitzer T, Sefler A, Shearer B, Moore JT, Miller AB, Willson TM, Williams SP (2002). "Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids". Structure 10 (9): 1225-34. doi:10.1016/S0969-2126(02)00829-8. PMID 12220494.
- ↑ Dhe-Paganon S, Duda K, Iwamoto M, Chi YI, Shoelson SE (2002). "Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand". J Biol Chem 277 (41): 37973-6. doi:10.1074/jbc.C200420200. PMID 12193589.
- ↑ Duda K, Chi YI, Shoelson SE (2004). "Structural basis for HNF-4alpha activation by ligand and coactivator binding". J Biol Chem 279 (22): 23311-6. doi:10.1074/jbc.M400864200. PMID 14982928.
- ↑ Fajans SS, Bell GI, Polonsky KS (2001). "Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young". N Engl J Med 345 (13): 971-80. doi:10.1056/NEJMra002168. PMID 11575290.
External links
Transcription factors and intracellular receptors | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1) Basic domains |
| ||||||||||||
| (2) Zinc finger DNA-binding domains |
| ||||||||||||
| (3) Helix-turn-helix domains |
| ||||||||||||
| (4) β-Scaffold factors with minor groove contacts |
| ||||||||||||
| (0) Other transcription factors |
| ||||||||||||
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies